Newsom Angers Left With Veto Of Abortion ‘Sanctuary’ Bill

California Gov. Gavin Newsom has frustrated progressive allies by rejecting legislation that would have barred future governors from honoring certain out-of-state extradition requests involving abortion and gender-related medical care.

The Democratic governor vetoed Assembly Bill 2164 late last week, declining to place into state law protections that largely reflect an executive policy he adopted in 2022.

Newsom defended the decision as a matter of preserving the governor’s constitutional authority. He did not signal a retreat from California’s broader support for abortion access or transgender medical services.

That distinction offered little reassurance to abortion-rights organizations, which wanted the protections to survive changes in political leadership.

AB 2164 would have prohibited California governors from extraditing individuals accused elsewhere of crimes involving reproductive or gender-related health care that is lawful in California. By putting that prohibition into statute, supporters sought to make providers’ protection less dependent on the discretion of a particular governor.

Newsom’s veto leaves that question more exposed to future elections.

His existing executive policy directs California officials to reject certain extradition demands concerning reproductive care permitted under California law. But a successor could potentially approach those requests differently.

Pavitra Abraham, state campaigns director for Reproductive Freedom for All, warned that providers remain “just one election away from extradition.”

For the bill’s supporters, the prospect of a future governor changing course was precisely the reason to pursue legislation. They argue that medical providers should not have to rely on the political commitments of whoever controls the executive branch.

The disagreement is particularly striking because Newsom has already used his authority to block an extradition request in an active interstate dispute.

Earlier this year, Louisiana sought the extradition of a California physician accused of prescribing abortion medication through telehealth to a patient in Louisiana. Newsom refused the request in January.

“Louisiana’s request is denied,” Newsom said at the time. “My position on this has been clear since 2022: We will not allow extremist politicians from other states to reach into California and try to punish doctors based on allegations that they provided reproductive health care services.”

The governor’s latest decision preserves his ability to take that position while declining to impose the bill’s restriction on future occupants of the office.

Organizations opposed to gender-related medical interventions for minors welcomed the veto, although their objections to the legislation differed from Newsom’s stated rationale.

Those groups argued that the measure could insulate California physicians from legal accountability when treating patients who live in states that restrict such interventions.

The bill encompassed both “reproductive health care services” and “gender affirming health care services,” placing disputes over abortion and gender-related treatment within the same proposed extradition protections.

Critics also raised questions about the Constitution’s Full Faith and Credit Clause and the extent to which one state must recognize certain proceedings originating in another.

Those objections reflect a broader conflict over state sovereignty: California seeks to protect conduct it permits, while other states seek to enforce restrictions affecting their residents.

Despite the veto, California’s extensive abortion shield-law framework remains in place.

Since the Supreme Court overturned Roe v. Wade in 2022, the state has adopted numerous measures limiting cooperation with investigations and legal proceedings brought by states seeking to penalize abortion providers for conduct lawful in California.

Newsom expanded those protections again in 2025.

Among the measures he signed was AB 260, which strengthened protections for providers prescribing abortion medication. In certain circumstances, it also allowed physicians to keep their names off prescription labels.

Such provisions have become increasingly consequential as telehealth and mailed medication allow abortion services to cross state lines without either the physician or the patient traveling.

A doctor practicing in California or New York can prescribe mifepristone remotely and arrange for the medication to be mailed to a patient in a state with significant abortion restrictions.

New York’s shield law expressly protects providers physically located in that state who deliver reproductive care through telehealth to patients elsewhere.

The resulting disputes place competing state policies in direct conflict. A prescription issued from a state that protects abortion access may reach a patient in a jurisdiction whose laws sharply restrict it.

Federal regulation adds another dimension to that confrontation.

Louisiana’s ongoing challenge to Food and Drug Administration rules governing mifepristone seeks tighter restrictions on how the drug may be prescribed and distributed.

Louisiana and other challengers argue that the FDA improperly relaxed safeguards that previously required more in-person medical supervision. A three-judge panel of the 5th U.S. Circuit Court of Appeals recently heard arguments in the case.

Current FDA rules allow mifepristone to be prescribed through telehealth and delivered by mail, facilitating prescriptions from providers in shield-law states to patients outside their borders.

Louisiana contends that those federal policies undermine its ability to enforce its own abortion laws.

Newsom’s veto does not resolve those interstate conflicts or dismantle California’s existing protections. It does, however, deny progressive organizations the statutory extradition barrier they sought—and preserves a consequential role for future governors in deciding how California responds.